Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 180 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Revolade Tablets Specified Drug-use Survey

 		Aplastic Anemia Japan

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

 		Sjögrens Disease, Systemic Lupus Erythematosus, Rheumatoid Arthritis Phase2 United States

Home Reported Outcomes in PNH

 		Paroxysmal Nocturnal Hemoglobinuria United States

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

 		Breast Cancer Phase1, Phase2 Spain
Singapore

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

 		Steroid-refractory Acute Graft Versus Host Disease Phase4 China

A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

 		Hypercholesterolemia Phase4 Germany

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

 		Hidradenitis Suppurativa France

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

 		Lupus Nephritis Taiwan

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

 		Atypical Hemolytic Uremic Syndrome Phase3 Brazil

Study of Safety and of the Mechanism of BLZ945 in ALS Patients

 		Amyotrophic Lateral Sclerosis Phase2 Australia